Xiaoxiao Sun

Sep 17, 2024 | nature.com | Xiaoxiao Sun |Steven J. Altschuler

AbstractDisease relapse driven by acquired drug resistance limits the effectiveness of most systemic anti-cancer agents. Targeting persistent cancer cells in residual disease before relapse has emerged as a potential strategy for enhancing the efficacy and the durability of current therapies. However, barriers remain to implementing persister-directed approaches in the clinic.

Mar 13, 2024 | mdpi.com | Shutong Wang |Zefan Wang |Xiaoxiao Sun |Yanhai Chang

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

May 25, 2023 | bmjopen.bmj.com | Shuying Li |Li Feng |Xiaoxiao Sun |Jie Ding

http://orcid.org/0000-0002-7232-9177Shuying Li, Li Feng, Xiaoxiao Sun, Jie Ding, Weihong Zhou Department of Health Management Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China Correspondence to Professor Weihong Zhou; njzhouwh{at}126.com; Jie Ding; 38410749{at}qq.com Abstract Objective The purposes of the study were to investigate the detailed association of serum uric acid (SUA) with visceral fat area (VFA) and body fat...